Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Alectinib is a highly selective ALK (Anaplastic Lymphoma Kinase) inhibitor. It has demonstrated efficacy in both systemic and central nervous system (CNS) treatment for Non-Small-Cell Lung Carcinoma (NSCLC) (ALK m) (2)
A randomized, open-label, phase III treatment trial with 303 assigned patients with previously untreated, advanced Non-Small-Cell Lung Carcinoma (NSCLC) (ALK m) evaluating either alectinib (600 mg twice dail…